Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $370000.0.

  • Amphastar Pharmaceuticals' Gains from Investment Securities fell 9453.72% to $370000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 11869.1%. This contributed to the annual value of $6.7 million for FY2024, which is 1426.22% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Gains from Investment Securities stood at $370000.0 for Q3 2025, which was down 9453.72% from $2.9 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Gains from Investment Securities' 5-year high stood at $9.5 million during Q1 2021, with a 5-year trough of $370000.0 in Q3 2025.
  • Moreover, its 5-year median value for Gains from Investment Securities was $6.3 million (2024), whereas its average is $5.5 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Gains from Investment Securities surged by 42788.13% in 2021 and then tumbled by 9453.72% in 2025.
  • Amphastar Pharmaceuticals' Gains from Investment Securities (Quarter) stood at $2.6 million in 2021, then crashed by 56.08% to $1.1 million in 2022, then skyrocketed by 368.12% to $5.4 million in 2023, then crashed by 31.39% to $3.7 million in 2024, then crashed by 89.96% to $370000.0 in 2025.
  • Its Gains from Investment Securities was $370000.0 in Q3 2025, compared to $2.9 million in Q2 2025 and $7.8 million in Q1 2025.